Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
3.890
-0.030 (-0.77%)
Sep 15, 2025, 2:32 PM EDT - Market open
Kyverna Therapeutics Market Cap
Kyverna Therapeutics has a market cap or net worth of $168.23 million as of September 15, 2025. Its market cap has decreased by -51.57% in one year.
Market Cap
168.23M
Enterprise Value
-36.24M
1-Year Change
-51.57%
Ranking
Category
Stock Price
$3.89
Market Cap Chart
Since the IPO on February 8, 2024, Kyverna Therapeutics's market cap has decreased from $898.10M to $168.23M, a decrease of -81.27%. That is a compound annual growth rate of -65.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 169.52M | 4.99% |
| Dec 31, 2024 | 161.46M | -82.02% |
| Feb 8, 2024 | 898.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |